These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11248905)

  • 1. Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach.
    Winterholler MG; Erbguth FJ; Wolf S; Kat S
    J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):417-8. PubMed ID: 11248905
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and administration of treatment with botulinum neurotoxin for sialorrhoea in ALS patients: review of the literature and a proposal for tailored treatment.
    Stokholm MG; Bisgård C; Vilholm OJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Dec; 14(7-8):516-20. PubMed ID: 23984863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis.
    Giess R; Naumann M; Werner E; Riemann R; Beck M; Puls I; Reiners C; Toyka KV
    J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):121-3. PubMed ID: 10864618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
    Tan EK; Lo YL; Seah A; Auchus AP
    J Neurol Sci; 2001 Sep; 190(1-2):95-7. PubMed ID: 11574113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
    Verma A; Steele J
    Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
    Meijer JW; van Kuijk AA; Geurts AC; Schelhaas HJ; Zwarts MJ
    Am J Phys Med Rehabil; 2008 Apr; 87(4):321-4. PubMed ID: 18303472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Sialorrhea in Amyotrophic Lateral Sclerosis #299.
    Scott K; Shannon R; Roche-Green A
    J Palliat Med; 2016 Jan; 19(1):110-1. PubMed ID: 26651368
    [No Abstract]   [Full Text] [Related]  

  • 8. Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis.
    Costa J; Rocha ML; Ferreira J; Evangelista T; Coelho M; de Carvalho M
    J Neurol; 2008 Apr; 255(4):545-50. PubMed ID: 18283399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease.
    Contarino MF; Pompili M; Tittoto P; Vanacore N; Sabatelli M; Cedrone A; Rapaccini GL; Gasbarrini G; Tonali PA; Bentivoglio AR
    Parkinsonism Relat Disord; 2007 Jul; 13(5):299-303. PubMed ID: 16807056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: a clinical and neurophysiological study.
    Gilio F; Iacovelli E; Frasca V; Gabriele M; Giacomelli E; Picchiori F; Soldo P; Cipriani AM; Ruoppolo G; Inghilleri M
    Amyotroph Lateral Scler; 2010 Aug; 11(4):359-63. PubMed ID: 19929745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients.
    Jackson CE; Gronseth G; Rosenfeld J; Barohn RJ; Dubinsky R; Simpson CB; McVey A; Kittrell PP; King R; Herbelin L;
    Muscle Nerve; 2009 Feb; 39(2):137-43. PubMed ID: 19145653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a treatment effective and safe for sialorrhea in people with amyotrophic lateral sclerosis (ALS)? Summary of a Cochrane Systematic Review.
    Cantisani TA
    Neurol Sci; 2023 Sep; 44(9):3083-3085. PubMed ID: 37326935
    [No Abstract]   [Full Text] [Related]  

  • 13. Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease.
    Guidubaldi A; Fasano A; Ialongo T; Piano C; Pompili M; Mascianà R; Siciliani L; Sabatelli M; Bentivoglio AR
    Mov Disord; 2011 Feb; 26(2):313-9. PubMed ID: 21259343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Radiation Therapy and Botulinum Toxin Injections in the Management of Sialorrhea in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review.
    Shehee L; O'Rourke A; Garand KL
    J Clin Neuromuscul Dis; 2020 Jun; 21(4):205-221. PubMed ID: 32453096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of sialorrhea with botulinum toxin: an overview].
    Hagenah J; Kahl KG; Steinlechner S; Lencer R; Klein C
    Nervenarzt; 2005 Apr; 76(4):418-25. PubMed ID: 15448912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the effectiveness of botulinum toxin for sialorrhoea.
    Truong DD; Bhidayasiri R
    J Neural Transm (Vienna); 2008; 115(4):631-5. PubMed ID: 18250951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin in the management of sialorrhoea: a systematic review.
    Lim M; Mace A; Nouraei SA; Sandhu G
    Clin Otolaryngol; 2006 Aug; 31(4):267-72. PubMed ID: 16911641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volume matters: the influence of different botulinum toxin-A dilutions for sialorrhea in amyotrophic lateral sclerosis.
    Anagnostou E; Rentzos M; Alexakis T; Zouvelou V; Zambelis T; Evdokimidis I
    Muscle Nerve; 2013 Feb; 47(2):276-8. PubMed ID: 23281147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of subcutaneous glycopyrrolate in the management of sialorrhoea and facilitating the use of non-invasive ventilation in amyotrophic lateral sclerosis.
    Cooper-Knock J; Ahmedzai SH; Shaw P
    Amyotroph Lateral Scler; 2011 Nov; 12(6):464-5. PubMed ID: 21554032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis.
    Stone CA; O'Leary N
    J Pain Symptom Manage; 2009 Feb; 37(2):246-58. PubMed ID: 18676117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.